Tech Company Financing Transactions

Orexigen Therapeutics Funding Round

Domain Associates, Kleiner Perkins Caufield & Byers and Montreux Equity Partners participated in a $35 million venture round for Orexigen Therapeutics. The round was recorded on 6/30/2005.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3344 N. Torrey Pines Ct. 200
La Jolla, CA 92037
USA

Phone

(858) 436-8600

Website

www.orexigen.com

Email Address

[email protected]

Overview

OREXIGEN is studying a novel, and potentially more effective way, to achieve and sustain weight loss through a combined, two-drug approach.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Michael Narachi

        

Chief Financial Officer

Monica Forbes

        

Chief Operating Officer

Thomas Cannell

        

VP - Bus. Development

Peter Flynn

        

VP - General Counsel

Thomas Lynch

        

Browse more venture capital transactions:

Prev: 6/30/2005: Pathwork Diagnostics venture capital transaction
Next: 6/30/2005: IP Fabrics venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary